No matter what country you were born or grew up in, it’s a proved statistic that women have far fewer heart problems than men.
Moreover, for women heart attack symptoms are not exactly the classical reality, a fact that can lead to administration of inadequate treatment, say U.S. doctors.
Starting from the study of the “British Heart Foundation”, we tried to outline a map with features of cardiac problems in Romania, through Mr. Aws Adnan interventional cardiologist doctor, University Emergency Hospital, Bucharest.
There is hope for patients with cardiovascular disease. People hospitalized for a heart attack or severe pain in the chest are at risk of relapse and mortality significantly reduced with a new anticoagulant Xarelto, Johnson & Johnson Laboratories and Bayer, according to results of a large clinical trial published this month.
Xarelto – which is the active molecule rivaroxaban – is administered orally in combination with a standard anticoagulant.
The authors of this study in the online version of the U.S. medical journal New England Journal of Medicine, said that Xarelto would still have a drawback: it would result in increased risk of major bleeding than other treatments to make the blood more fluid.
- Tips to Use Coupons to Save Money on Your Groceries
- Top gifts for gardeners in 2013
- A secure home for a secure family
- What are the risks of not getting enough sleep?
- Flinders Chase National Park promises spectacular scenery and fascinating wildlife
- Rise of the Female Trader
- 5 Wedding Presents Ideas for a Young Couple
- New Wiring Norms For UK Electricians: Your Man Needs to Know This
- Basic tips to pick your gaming room furniture wisely
- Fantastic Hedge Trimmers